Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-12-330556
Filing Date
2012-08-02
Accepted
2012-08-02 09:17:23
Documents
4
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d387626d10ka.htm 10-K/A 33887
2 DEVELOPMENT AND OPTION AGREEMENT d387626dex1062.htm EX-10.62 1085244
3 CERTIFICATION BY CHIEF EXECUTIVE OFFICER d387626dex311.htm EX-31.1 3123
4 CERTIFICATION BY CHIEF FINANCIAL OFFICER d387626dex312.htm EX-31.2 3130
  Complete submission text file 0001193125-12-330556.txt   1126342
Mailing Address 730 STOCKTON DRIVE EXTON PA 19341
Business Address 730 STOCKTON DRIVE EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

EIN.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-21699 | Film No.: 121001976
SIC: 2834 Pharmaceutical Preparations